Dupilumab suppression of Th2 biomarkers correlates with reduction in transepidermal water loss (TEWL) and clinical improvements in adults with moderate-to-severe atopic dermatitis (AD)

被引：0
|
作者：
Hamilton, J. [1 ]
Hamon, S. [1 ]
Chaudhry, U. [1 ]
Simpson, E. L. [2 ]
Swanson, B. [3 ]
Liu, M. [4 ]
Ren, H. [4 ]
Graham, N. [1 ]
Pirozzi, G. [3 ]
Ardeleanu, M. [1 ]
机构：
[1] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[2] Oregon Hlth & Sci Univ, Portland, OR USA
[3] Sanofi, Bridgewater, NJ USA
[4] Regeneron Pharmaceut Inc, Basking Ridge, NJ USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2015年 / 135卷
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
169
引用
收藏
页码：S29 / S29
页数：1
相关论文
共 50 条
  • [41] Laboratory safety of dupilumab in moderate-to-severe atopic dermatitis: results from three phase III trials (LIBERTY AD SOLO 1, LIBERTY AD SOLO 2, LIBERTY AD CHRONOS)
    Wollenberg, A.
    Beck, L. A.
    Blauvelt, A.
    Simpson, E. L.
    Chen, Z.
    Chen, Q.
    Shumel, B.
    Khokhar, F. A.
    Hultsch, T.
    Rizova, E.
    Rossi, A. B.
    Graham, N. M. H.
    Pirozzi, G.
    Lu, Y.
    Ardeleanu, M.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (05) : 1120 - 1135
  • [42] Efficacy and Safety of Dupilumab Maintained in Adults=60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials
    Silverberg, Jonathan I.
    Lynde, Charles W.
    Abuabara, Katrina
    Patruno, Cataldo
    de Benedetto, Anna
    Zhang, Haixin
    Thomas, Ryan B.
    Bego-Le-Bagousse, Gaelle
    Khokhar, Faisal A.
    Vakil, Jignesh
    Rodriguez Marco, Ainara
    Levit, Noah A.
    AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2023, 24 (03) : 469 - 483
  • [43] Dupilumab Treatment Results in Rapid Improvement in Itch in Adult and Adolescent Patients With Moderate-to-Severe Atopic Dermatitis (LIBERTY AD SOLO 1 & 2, and ADOL trials)
    Yosipovitch, Gil
    Hong, Chih-ho
    Simpson, Eric
    Eckert, Laurent
    Chen, Zhen
    Mina-Osorio, Paola
    Gadkari, Abhijit
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB190 - AB190
  • [44] Dupilumab in Moderate-to-Severe Atopic Dermatitis With or Without Comorbid Food Allergy: Pooled Analysis of 2 Randomized Phase 3 Trials (LIBERTY AD SOLO 1 & 2)
    Simpson, Eric L.
    Lacour, Jean-Philippe
    Silverberg, Jonathan I.
    Worm, Margitta
    Wollenberg, Andreas
    Graham, Neil M. H.
    Pirozzi, Gianluca
    Akinlade, Bolanle
    Eckert, Laurent
    Gadkari, Abhijit
    Ardeleanu, Marius
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (02) : AB131 - AB131
  • [45] Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials
    Jonathan I. Silverberg
    Mark Boguniewicz
    Jon Hanifin
    Kim A. Papp
    Haixin Zhang
    Ana B. Rossi
    Noah A. Levit
    Dermatology and Therapy, 2022, 12 : 2731 - 2746
  • [46] Dupilumab Treatment in Adults with Moderate-to-Severe Atopic Dermatitis is Efficacious Regardless of Age of Disease Onset: a Post Hoc Analysis of Two Phase 3 Clinical Trials
    Silverberg, Jonathan, I
    Boguniewicz, Mark
    Hanifin, Jon
    Papp, Kim A.
    Zhang, Haixin
    Rossi, Ana B.
    Levit, Noah A.
    DERMATOLOGY AND THERAPY, 2022, 12 (12) : 2731 - 2746
  • [47] Efficacy and Safety of Dupilumab Maintained in Adults ≥ 60 Years of Age with Moderate-to-Severe Atopic Dermatitis: Analysis of Pooled Data from Four Randomized Clinical Trials
    Jonathan I. Silverberg
    Charles W. Lynde
    Katrina Abuabara
    Cataldo Patruno
    Anna de Benedetto
    Haixin Zhang
    Ryan B. Thomas
    Gaëlle Bégo-Le-Bagousse
    Faisal A. Khokhar
    Jignesh Vakil
    Ainara Rodríguez Marco
    Noah A. Levit
    American Journal of Clinical Dermatology, 2023, 24 : 469 - 483
  • [48] Dupilumab Improves Symptoms of Anxiety and Depression in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Three Phase 3 Trials (LIBERTY AD SOLO 1 & 2 and ADOL)
    Silverberg, Jonathan
    Soong, Weily
    Lockshin, Benjamin
    Gadkari, Abhijit
    Chen, Zhen
    Bansal, Ashish
    Eckert, Laurent
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2020, 145 (02) : AB191 - AB191
  • [49] Dupilumab treatment results in early and sustained improvements in itch in adolescents and adults with moderate to severe atopic dermatitis: Analysis of the randomized phase 3 studies SOLO 1 and SOLO 2, AD ADOL, and CHRONOS
    Silverberg, Jonathan I.
    Yosipovitch, Gil
    Simpson, Eric L.
    Kim, Brian S.
    Wu, Jashin J.
    Eckert, Laurent
    Guillemin, Isabelle
    Chen, Zhen
    Ardeleanu, Marius
    Bansal, Ashish
    Kaur, Mandeep
    Rossi, Ana B.
    Graham, Neil M. H.
    Patel, Naimish
    Gadkari, Abhijit
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) : 1328 - 1336
  • [50] IMPROVEMENTS IN CLINICAL AND PATIENT REPORTED OUTCOMES WITH ETRASIMOD, A NOVEL, ORAL, SELECTIVE SPHINGOSINE 1-PHOSPHATE RECEPTOR MODULATOR, IN ADULTS WITH MODERATE-TO-SEVERE ATOPIC DERMATITIS
    Guttman-Yassky, Emma
    Bissonette, Robert
    Kircik, Leon
    Murrell, Dedee
    Selfridge, Andrew
    Liu, Kris
    Ahuluwalia, Gurpreet
    Silverberg, Jonathan
    ACTA DERMATO-VENEREOLOGICA, 2021, 101 : 62 - 63
12345